These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34818553)

  • 1. Protein kinase C
    Kenchappa RS; Liu Y; Argenziano MG; Banu MA; Mladek AC; West R; Luu A; Quiñones-Hinojosa A; Hambardzumyan D; Justilien V; Leitges M; Sarkaria JN; Sims PA; Canoll P; Murray NR; Fields AP; Rosenfeld SS
    Cell Rep; 2021 Nov; 37(8):110054. PubMed ID: 34818553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
    Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
    Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent copy number gains drive PKCι expression and PKCι-dependent oncogenic signaling in human cancers.
    Liu Y; Justilien V; Fields AP; Murray NR
    Adv Biol Regul; 2020 Dec; 78():100754. PubMed ID: 32992230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKCι maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis.
    Wang Y; Hill KS; Fields AP
    Mol Cancer Res; 2013 Dec; 11(12):1624-35. PubMed ID: 24174471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling.
    Baldwin RM; Garratt-Lalonde M; Parolin DA; Krzyzanowski PM; Andrade MA; Lorimer IA
    Oncogene; 2006 May; 25(20):2909-19. PubMed ID: 16331246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo.
    Murray NR; Jamieson L; Yu W; Zhang J; Gökmen-Polar Y; Sier D; Anastasiadis P; Gatalica Z; Thompson EA; Fields AP
    J Cell Biol; 2004 Mar; 164(6):797-802. PubMed ID: 15024028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma.
    Yin N; Liu Y; Khoor A; Wang X; Thompson EA; Leitges M; Justilien V; Weems C; Murray NR; Fields AP
    Cancer Cell; 2019 Aug; 36(2):156-167.e7. PubMed ID: 31378680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis.
    Wang Y; Justilien V; Brennan KI; Jamieson L; Murray NR; Fields AP
    Oncogene; 2017 Jan; 36(4):534-545. PubMed ID: 27321186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity.
    Regala RP; Weems C; Jamieson L; Copland JA; Thompson EA; Fields AP
    J Biol Chem; 2005 Sep; 280(35):31109-15. PubMed ID: 15994303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway.
    Liu SG; Wang BS; Jiang YY; Zhang TT; Shi ZZ; Yang Y; Yang YL; Wang XC; Lin DC; Zhang Y; Yang H; Cai Y; Zhan QM; Wang MR
    Mol Cancer Res; 2011 Apr; 9(4):390-402. PubMed ID: 21310827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
    Fields AP; Frederick LA; Regala RP
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of oncogenic protein kinase Ciota signaling in lung adenocarcinoma.
    Erdogan E; Klee EW; Thompson EA; Fields AP
    Clin Cancer Res; 2009 Mar; 15(5):1527-33. PubMed ID: 19223491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma.
    Ito M; Codony-Servat C; Codony-Servat J; Lligé D; Chaib I; Sun X; Miao J; Sun R; Cai X; Verlicchi A; Okada M; Molina-Vila MA; Karachaliou N; Cao P; Rosell R
    Cell Commun Signal; 2019 Oct; 17(1):137. PubMed ID: 31660987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordination of glioblastoma cell motility by PKCι.
    Baldwin RM; Barrett GM; Parolin DA; Gillies JK; Paget JA; Lavictoire SJ; Gray DA; Lorimer IA
    Mol Cancer; 2010 Sep; 9():233. PubMed ID: 20815904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival function of protein kinase C{iota} as a novel nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-activated bad kinase.
    Jin Z; Xin M; Deng X
    J Biol Chem; 2005 Apr; 280(16):16045-52. PubMed ID: 15705582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells.
    Stallings-Mann M; Jamieson L; Regala RP; Weems C; Murray NR; Fields AP
    Cancer Res; 2006 Feb; 66(3):1767-74. PubMed ID: 16452237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids.
    Linch M; Sanz-Garcia M; Rosse C; Riou P; Peel N; Madsen CD; Sahai E; Downward J; Khwaja A; Dillon C; Roffey J; Cameron AJ; Parker PJ
    Carcinogenesis; 2014 Feb; 35(2):396-406. PubMed ID: 24072773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis.
    Scotti ML; Bamlet WR; Smyrk TC; Fields AP; Murray NR
    Cancer Res; 2010 Mar; 70(5):2064-74. PubMed ID: 20179210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic protein kinase Cι signaling mechanisms in lung cancer: Implications for improved therapeutic strategies.
    Yin N; Liu Y; Murray NR; Fields AP
    Adv Biol Regul; 2020 Jan; 75():100656. PubMed ID: 31623973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation.
    Justilien V; Fields AP
    Oncogene; 2009 Oct; 28(41):3597-607. PubMed ID: 19617897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.